Clinical Trial: Biopsy-site-marker in Breast Cancer

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833566) titled 'Biopsy-site-marker in Breast Cancer' on Sept. 16.

Brief Summary: The purpose of this study is to explore pro-metastatic changes in breast cancer (BC) associated with the stiffness of biopsy site markers. This study aims to determine whether the stiffness of a biopsy site marker promotes inflammatory changes in breast cancer and to evaluate whether there is a relationship between biopsy site marker stiffness and inflammation.

Study Start Date: July 09

Study Type: OBSERVATIONAL

Condition: Breast Cancer

Intervention: DEVICE: Biopsy-Site Marker Placement.

Tissue samples will be collected from Breast Cancer patients, stages I-III...